Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2019-11-19 2019-11-18
Drug Identification Number 02131692 02131692
Brand name BLEOMYCIN FOR INJECTION USP BLEOMYCIN FOR INJECTION USP
Common or Proper name BLEOMYCIN FOR INJECTION USP BLEOMYCIN FOR INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients BLEOMYCIN BLEOMYCIN
Strength(s) 15UNIT 15UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 x 15iu vial 1 x 15iu vial
ATC code L01DC L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-30 2019-09-30
Estimated end date
Actual end date 2019-11-18 2019-11-18
Shortage status Resolved Actual shortage
Company comments
Health Canada comments